A comparison of antihypertensive medication utilization before and after guideline changes using the Department of Defense Prescription Database

Annals of Pharmacotherapy

Volumn 33, Issue 5, 1999, Pages 548-553

  Okano, Gary J ^a   Rascati, Karen L ^c   Wilson, James P ^d   Remund, Daniel D ^b  

^a Strategic Outcomes Services Inc   (United States)

^b Medical Service Corps   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d NONE

Author keywords

Antihypertensives; Drug utilization

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARMY; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG UTILIZATION; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

EID: 0033056871     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809903300501     Document Type: Article

References (19)

1. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1993;153:154-83.
2. American Heart Association. Heart and stroke facts: 1996 statistical supplement. Dallas, TX: AHA, 1995.
3. McLaughlin TJ. Hypertension disease management in organized systems of care. Spectrum 1995;(June):1-9.
4. The 1988 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1988;148: 1023-38.
5. Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 1994;17:1247-51.
6. Pogue VA, Ellis C, Michel J, Francis CK. New staging system of the fifth Joint National Committee report on the detection, evaluation, and treatment of high blood pressure (JNC-V) alters assessment of the severity and treatment of hypertension. Hypertension 1996;28:713-8.
7. Alderman MH, Madhavan S, Cohen H. Antihypertensive drug therapy. The effects of JNC criteria on prescribing patterns and patient status through the first year. Am J Hypertens 1996;9:413-8.
8. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the detection, evaluation, and treatment of high blood pressure. JAMA 1997;278:1778-9.
9. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q 1989;67:268-317.
10. Okano GJ, Rascati KL. Effects of Medicaid drug utilization review intervention letters. Clin Ther 1995;17:525-33.
11. Rascati KL, Okano GJ, Burch C. Evaluation of physician intervention letters. Med Care 1996;34:760-6.
12. Collins TM, Mott DA, Bigelow WE, Zimmerman DR. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach. Health Serv Res 1997;34:471-89.
13. Smith DH, Christensen DB, Stergachis A, Homes G. A randomized controlled trial of a drug use review intervention for sedative hypnotic medications. Med Care 1998;36:1013-21.
14. Gillings D, Makuk D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health 1981;71:38-46.
15. Psaty BM, Koepsell TD, Yanez ND, Smith NL, Manolio TA, Heckbert SR, et al. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992. An effect of the major clinical trials on clinical practice? JAMA 1995;273:1436-8.
16. Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP. Thiazide diuretics and the risk of hip fractures. JAMA 1991;265:370-3.
17. Kaplan NM. The treatment of hypertension in women. Arch Intern Med 1995;155:563-5.
18. Fankhauser MP. Premenstrual syndrome. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiological approach. 3rd ed. Stamford, CT: Appleton and Lange, 1997:1621.
19. The sixth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Washington, DC: U.S. Department of Health and Human Services, 1997; NIH publication no. 98-4080.